Effects of neonatal 5,7-dihydroxytryptamine treatment on the development of serotonin neurons and their transmitter metabolism.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000032:analysis; D000818:Animals; D000831:Animals, Newborn; D001933:Brain Stem / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects / Q000254:growth & development*; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis; D006719:Homovanillic Acid / Q000032:analysis; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D051381:Rats; D012701:Serotonin / Q000032:analysis / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism
D004102:Dihydroxytryptamines; D015102:3,4-Dihydroxyphenylacetic Acid; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid